secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-010582
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead issues $700M zero-coupon convertible notes due 2032; enters capped call to reduce dilution
--------------------------------------------------------------------------------

- Arrowhead issued $700M 0.00% convertible senior notes due 2032; conversion price ~$87.07 per share.
- Entered capped call transactions costing ~$47.9M to reduce potential dilution from conversion.
- Underwriters' over-allotment option of $75M fully exercised; total notes issued $700M.
- Notes mature Jan 15, 2032; no regular interest; special interest up to 0.50% for reporting failures.
- Initial conversion rate 11.4844 shares per $1,000 principal; redeemable after Jan 16, 2029 under conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/0001193125-26-010582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/d19865d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-010582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer